Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
mTOR & rapamycin
Research brief

Rapamycin in fruit flies: sex-biased aging trajectory in a single-nucleus atlas

In a whole-organism single-nucleus atlas of fruit flies, rapamycin reduced a convergent aging trajectory that accumulated with age, especially in females; the abstract reports this as an atlas framework, not a human lifespan result. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The atlas covers both sexes, multiple ages, 18 cell classes and 181 cell types of Drosophila. [1]

  2. A rapamycin-sensitive Convergent Aging Trajectory was marked by Fkbp12 enrichment and mTORC1-linked metabolic programs. [1]

  3. CAT-high nuclei accumulated with age and were preferentially reduced by rapamycin, especially in females. [1]

The source at a glance

Study type / format
Whole-organism single-nucleus transcriptomic atlas (abstract)
Population / context
Fruit flies (Drosophila) of both sexes at multiple ages
Summary based on
Study abstract
Publication status
Preprint · peer-review status not confirmed
Original publication
July 3, 2026

Fly atlas across sexes, ages and cell types

The authors built the Rapamycin Fly Cell Atlas, a whole-organism single-nucleus transcriptomic atlas of the fruit fly Drosophila. It covers both sexes, multiple ages, 18 cell classes and 181 cell types. Rapamycin's response was highly heterogeneous: effects were prominent in reproductive, digestive and neuromuscular systems and modest in most neuronal populations.

Supporting source [1]

Aging trajectory high in Fkbp12 reduced by rapamycin

Across diverse tissues the authors identified a rapamycin-sensitive Convergent Aging Trajectory (CAT), marked by enrichment of Fkbp12 and mTORC1-linked metabolic programs such as glycolysis and lipid synthesis. Nuclei high in CAT accumulated with age and were preferentially reduced by rapamycin, especially in females. The authors note this is consistent with stronger female lifespan extension.

Supporting source [1]

Mapping geroprotection by sex and cell type

By combining CAT abundance, aging-clock predictions and changes in nucleus ratios, the authors mapped sex- and cell-type-specific geroprotection effects of rapamycin. They present the atlas as an organism-wide framework for studying how rapamycin reshapes cellular aging across sex, tissue and cellular state.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. This is a Drosophila single-nucleus transcriptomic atlas, not a human study. The link to stronger female lifespan extension is described as consistent, not proven here, and the atlas is presented as a framework.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Rapamycin Mitigates a Sex-biased Convergent Aging Trajectory

Lu T, Liang C, Park Y, Auld N, Jackson T, Yin Z, Harrison E, Sun B, Qadiri M, Perrimon N, Hsu A, Qi Y, Li H. · europepmc.org · July 3, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    spanning both sexes, multiple ages, 18 cell
  2. Finding 2 ↑

    marked by Fkbp12 enrichment and mTORC1-linked metabolic
  3. Finding 3 ↑

    CAT-high nuclei accumulated with age and were

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…